The Bell Labs of biotech: Stuart Schreiber has billionaire support for new biomedical institute

A group of billionaires has invested in a new biomedical research institute, Arena BioWorks, with the aim of accelerating drug development and bringing medicines to patients more quickly. The institute, inspired by the success of Bell Labs, plans to lead new research initiatives and create for-profit biotech companies under one roof, promising a faster translational research model. It has the backing of several big names and intends to position scientists at the forefront of its operations, with a base in Kendall Square in Cambridge, MA, a hub for the biotech industry.

Key takeaways

A group of billionaires has invested in a new biomedical research institute, Arena BioWorks, with broad ambitions across technologies and disease areas.
Arena BioWorks aims to lead new research initiatives and create for-profit biotech companies under one roof.
The institute promises a quicker translational research model and has the backing of big names in the industry.
Arena BioWorks plans to put scientists in the driver's seat and establish a footprint in Kendall Square in Cambridge, MA, a hub for the biotech industry.

The Bell Labs of biotech: Stuart Schreiber has billionaire support for new biomedical institute

Key takeaways

Discussion (0)